Pharmacovigilance (PV) organizations today face significant challenges and opportunities:
- Explosive growth in case volume, often without commensurate resource increases
- Changing regulatory requirements and lack of harmonization across regions
- Availability of big data but difficulty leveraging it to support proactive drug safety and signal detection
- Complex technology environment with new platforms offering significant capabilities beyond traditional drug safety databases
- Increasing collaboration with partners and internal corporate functions
Satori’s pharmacovigilance offerings support clients in overcoming their challenges and realizing their opportunities: